| |
A SPECIAL
ANNOUNCEMENT FROM: |
|
 |
|
|
|
| |
| |
Upcoming Pharmacovigilance opportunities for your team, opportunities for knowledge exchange, and other updates of interest. Add EMEA@DIAglobal.org. |
|
|
|
|
| |
|
 |
|
|
 |
|
|
|
| |
| |
 |
|
Table of Content |
|
| |
|
|
| |
|
| |
|
| |
|
|
| |
|
| |
|
| |
|
|
|
|
|
| |
| |
| |
 |
|
|
| Diagnosis and Management of Drug-Induced Liver Injury: Clinical Trials and Post-Marketing |
| |
| 14-15 June 2016 | London, UK |
|
|
| |
| |
This training course is designed to be followed as a stand-alone course for those who would like to increase their knowledge on DILI or as an advised complement to the course titled Medical Approach in Diagnosis and Management of ADRs, which is taking place in the same venue immediately before the DILI Training Course. |
|
|
|
| |
|
|
| |
|
|
|
| |
| |
| |
|
|
|
| 10th Annual Forum for Qualified Persons in Pharmacovigilance |
| |
| 5-6 October 2016 | London, UK |
| |
|
|
| |
| |
Call for Poster Abstracts |
| |
Submission Deadline: 30 June 2016 |
| |
DIA and the Programme Committee invite you to submit a professional poster abstract.
Over the last 10 years a great community of experts and professionals in the field of Pharmacovigilance has developed to share research, key successes and discuss challenging issues.
|
| |
|
|
|
|
We encourage you to share your achievements and contribute with your work and ideas to showcasing the latest developments in the role of the QPPV.
Your poster should present on one of the following topics:
- Best practices in PSMF management
- QPPV offices
- Quality systems
Abstracts
will be selected by the Programme Committee. |
| |
|
|
|
|
|
| |
| |
| About DIA |
| |
| DIA is the non-profit organisation that advances health care product development around the world by connecting all stakeholders to interdisciplinary insights and innovation in a neutral forum. |
| |
| DIA provides an invaluable platform for collaboration and advancing your career by delivering customised learning experiences and building trusted relationships among individuals and organisations that share DIA's values. |
|
|
| |
|
| |
|
|
|
|
| |
| |
| |
|
| |
|
| |
| |
Medical Approach in Diagnosis and Management of ADRs
London, UK |
| |
| Considered by many experts as one of the pillars of medical training in PhV, this course focuses on how to use medical knowledge in the diagnosis and management of selected ADRs. |
| |
|
|
|
|
|
| |
|
| |
| |
Post-Authorisation Studies (PAS)
London, UK |
| |
| This course offers insight into EU legislation on PASS and PAES. Examples of PAS protocols as well as some examples of classic pitfalls in study conduct will be presented and discussed. |
| |
|
|
|
|
|
| |
|
| |
| |
Diagnosis and Management of Drug-Induced Liver Injury: Clinical Trials and Post-Marketing
London, UK |
| |
| This training course is designed to be followed as a stand-alone course for those who would like to increase their knowledge on DILI or as an advised complement to the course titled Medical Approach in Diagnosis and Management of ADRs, which is taking place in the same venue immediately before the DILI Training Course. |
| |
|
|
|
|
|
| |
|
| |
| |
Signal Management in Pharmacovigilance
London, UK |
| |
| The course will teach essential concepts of signal detection and signal management and how to apply them within the participants' functions. |
| |
|
|
|
|
|
| |
|
| |
|
| |
| |
In addition to our scheduled training courses, DIA offers Customised Training opportunities to fit your team's development needs and schedule.
Location of Your Choice |
| |
Leveraging the experience of our world-class faculty, we offer two options for tailored training:
- Select a private course from our public offerings; just for your employees, at your preferred location.
- Tailor a course specific to your team development needs, utilising a variety of proven training modules.
|
| |
|
|
|
|
|
|
| |
| |
 |
|
|
| |
| EudraVigilance & Information Days |
| |
|
|
|
| |
| Keep an eye on upcoming 2016 EMA EudraVigilance courses and Information Days. Courses fill up quickly and seats are limited - register today to reserve your space. More dates will be added as they are confirmed. |
|
|
|
|
|
|
|
| |
|
|
|
| |
| |
| |
| Join the DIA Members' Pharmacovigilance Community |
| |
| Connect, engage, and share. Now it's easier than ever to build a global, cross-functional network while sharing your expertise. With the new DIA Communities, you can: |
|
|
| |
| |
- Start a conversation: Hear from your colleagues and how they are addressing the latest challenges in your field
- Stay abreast of the day's discussions with your customised communities dashboard
- Build your network: Create your own list of DIA contacts of likeminded professionals through the Member Directory
|
|
|
|
|
| |
|
|
|
| |
|
|
|
| |
| |
|
|
|
|
|
| |
Want More Up-to-Date Information?
Subscribe to DIA Updates |
|
|
| |
We want to provide you with personally relevant information and news.
Opt-in to DIA email if you want news and information that is relevant to your current work setting and area of interest.
|
| |
|
|
| |
Read DIA's publication, the Global Forum, to find out about what's hot in the industry and the world of medicines development. No membership required.
Also check out DIA's Insightful Podcasts |
| |
|
| |
|
|
|
| Unsubscribe |
|
|
DIA Europe, Middle East & Africa
Kuechengasse 16
4051 Basel, Switzerland
|
| |
|
|
